PCORT Alum Christophter Lathan, MD was recently featured on Crico's Clinician's Resources site. Chris discusses his research on racial and class disparities in cancer care.

In the video below, Chris tells a story highlighting the importance of listening to patients. 

© 2012 CRICO, All Rights Reserved

 

NIH study examines the impact of tobacco control policies and programs, and the potential for further reduction in lung cancer deaths

Twentieth-century tobacco control programs and policies were responsible for preventing more than 795,000 lung cancer deaths in the United States from 1975 through 2000, according to an analysis funded by the National Cancer Institute (NCI), part of the National Institutes of Health.

Oct 6 (Reuters) - Starting breast cancer screening as early as age 25 may help women who carry a genetic mutation linked to a higher risk of cancer live longer, according to a U.S. study.

Researchers, whose findings were reported in the journal Cancer, looked at which breast cancer screenings -- mammogram or magnetic resonance imaging (MRI) -- were effective in women who carry the gene mutations BRCA1 and BRCA2, known to increase the risk of breast and ovarian cancer. They looked at women aged 25, 30, 35 and 40 years old.
By Ezekiel J. Emanuel and Steven D. Pearson
 
If you want to know what is wrong with American health care today, exhibit A might be the two new proton beam treatment facilities the Mayo Clinic has begun building, one in Minnesota, the other in Arizona, at a cost of more than $180 million dollars each. They are part of a medical arms race for proton beam machines, which could cost taxpayers billions of dollars for a treatment that, in many cases, appears to be no better than cheaper alternatives.
 
 

The use of CT scans has grown tremendously in the past three decades. The imaging tests, first widely used in the mid-1970s, have become a valuable tool for pinpointing tumors and blood clots, monitoring heart disease, and reducing the need for exploratory surgery. But there is evidence that their use has outpaced need.

The American Medical Association is taking public comment through the end of this week on a proposal to control use of the tests. There are a couple of good reasons for doing that.